- Home
- EXEL vs EQX Comparison
EXEL vs EQX Comparison
Compare EXEL & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | EQX |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.9B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | EQX |
|---|---|---|
| Price | $44.37 | $13.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 1 |
| Target Price | ★ $44.73 | $17.00 |
| AVG Volume (30 Days) | 2.5M | ★ 8.3M |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.55 | N/A |
| EPS | ★ 2.38 | 0.11 |
| Revenue | $2,288,218,000.00 | ★ $2,296,356,000.00 |
| Revenue This Year | $9.14 | $78.78 |
| Revenue Next Year | $12.51 | $60.10 |
| P/E Ratio | ★ $18.67 | $175.53 |
| Revenue Growth | 9.93 | ★ 85.65 |
| 52 Week Low | $31.90 | $4.95 |
| 52 Week High | $49.62 | $14.36 |
Technical Indicators
Market Signals| Indicator | EXEL | EQX |
|---|---|---|
| Relative Strength Index (RSI) | 63.52 | 66.28 |
| Support Level | $43.00 | $13.62 |
| Resistance Level | $44.79 | $14.27 |
| Average True Range (ATR) | 1.03 | 0.56 |
| MACD | 0.06 | 0.08 |
| Stochastic Oscillator | 83.48 | 84.30 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.